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SUMMARY
Chromatin ubiquitination by the ubiquitin ligase
RNF168 is critical to regulate the DNA damage
response (DDR). DDR deficiencies lead to cancer-
prone syndromes, but whether this reflects DNA
repair defects is still elusive. We identified key fac-
tors of the RNF168 pathway as essential mediators
of efficient DNA replication in unperturbed S phase.
We found that loss of RNF168 leads to reduced repli-
cation fork progression and to reversed fork accu-
mulation, particularly evident at repetitive sequences
stalling replication. Slow fork progression depends
onMRE11-dependent degradation of reversed forks,
implicating RNF168 in reversed fork protection and
restart. Consistent with regular nucleosomal organi-
zation of reversed forks, the replication function of
RNF168 requires H2A ubiquitination. As this novel
function is shared with the key DDR players ATM,
gH2A.X, RNF8, and 53BP1, we propose that dou-
ble-stranded ends at reversed forks engage classical
DDR factors, suggesting an alternative function of
this pathway in preventing genome instability and
human disease.
INTRODUCTION
Maintenance of genome stability is an active process within the
cells, which cope with the huge number of DNA lesions arising
both from exogenous (i.e., genotoxic drugs and irradiation) and
endogenous (i.e., DNA replication) sources. Ubiquitin (Ub)-medi-
ated post-translational modifications play essential roles in this
process, finely regulating both the DNA damage response
(DDR) and DNA replication (Smeenk and Mailand, 2016). A para-
digmatic example of the ubiquitination signaling role is repre-
sented by the pathway activated by DNA double-strand breaks
(DSBs). Upon DSB formation, the histone variant H2A.X is phos-
phorylated by the ATM kinase, leading to the recruitment of the
ubiquitinating pair RNF8/UBC13, which promotes K63-linked
ubiquitination (Smeenk and Mailand, 2016). These ubiquitinating
events allow the recruitment of the Ub ligase RNF168 to
damaged chromosomes, where it targets histones H2A and
H2A.X in a UbK27-dependent manner (Gatti et al., 2015).
Remarkably, RNF168 generates a highly specific mark on chro-
matin by modifying the N-terminal site of H2As on K13 and K15
(Gatti et al., 2012; Mattiroli et al., 2012), referred to as H2AK13/
15Ub. Ubiquitinated H2As represent the docking site for addi-
tional factors, such as 53BP1 and the BRCA1 complex, which
activate downstream events to repair damaged DNA by promot-
ing either non-homologous end joining (NHEJ) or homologous
recombination (HR), respectively.
RNF168’s activity and the H2AK13/15Ub histone mark are at
the hub of the DDR pathway, and their key role has been clearly
demonstrated by the identification of germline mutations in the
RNF168 gene as the cause of a combined disorder called
RIDDLE syndrome, characterized by radiosensitivity, immuno-
deficiency, microcephaly, growth retardation, and cancer pre-
disposition (Stewart et al., 2009). Similarly, mutations in the
apical kinase ATM are associated with the human syndrome
ataxia telangiectasia, which combines neurological defects
with immunosuppression and elevated cancer risk. Knockout
mouse models for all genes in this pathway are compatible
with life but display different combinations of phenotypes,
such as abnormal development, infertility, immunodeficiencies,
premature aging, and/or cancer predisposition (Specks et al.,
2015). Overall, while immunodeficiency and radiosensitivity are
clearly linked to the DSB response defect, the molecular mech-
anisms underlying the other defects are currently unknown.
Recent work has investigated the role of classical DSB pro-
cessing and signaling factors in response to replication stress.
HR factors have long been known to mediate specialized path-
ways of replication fork restart, although this was long assumed
to involve collapse of stalled forks into DSBs (Petermann and
Helleday, 2010). Moreover, DSB processing factors—such
as the MRE11 nuclease—were found to regulate ssDNA accu-
mulation on replication intermediates (Hashimoto et al., 2010).
The BRCA genes—key HR factors and tumor suppressors—
were shown to limit this MRE11-dependent fork resection,
preventing extensive degradation of newly synthesized DNA
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(Schlacher et al., 2011). This alternative function of these crucial
HR factors can be genetically uncoupled from their classical role
in DSB repair and was recently reported to underlie the exquisite
chemosensitivity observed in BRCA2-defective tumors (Ray
Chaudhuri et al., 2016; Schlacher et al., 2011). Differently from
DSB processing and repair, the relevance of the DSB signaling
pathway in DNA replication has not yet been thoroughly investi-
gated. Large 53BP1 foci in G1 phase—described as ‘‘53BP1 nu-
clear bodies’’ (Lukas et al., 2011)—arise as a consequence of
increased replication stress in the previous S phase via mitotic
processing of residual replication intermediates into DSBs.
Recently, Rad9/53BP1 was shown in yeast to protect stalled
forks from degradation (Villa et al., 2018) and to modulate in
mammals checkpoint signaling and stalled fork restart (Her
et al., 2018; Xu et al., 2017). However, these observations were
made upon exogenous genotoxic treatments, and a potential
role of DSB signaling factors in unperturbed replication has not
been investigated to date.
Replication fork remodeling into four-way junctions—also
known as replication fork reversal—has recently emerged as a
global response to a variety of conditions of replication stress,
including treatment with multiple genotoxins (Ray Chaudhuri
et al., 2012; Zellweger et al., 2015). Intriguingly, repetitive se-
quences prone to form secondary structures are also sufficient
to induce frequent fork reversal during unperturbed S phase
(Follonier et al., 2013). This transaction was proposed to limit
fork progression under unfavorable conditions, thereby prevent-
ing breakage of replicating chromosomes (Neelsen and Lopes,
2015). However, the regressed arm of reversed forks was also
recently shown to act as a necessary entry point for fork degra-
dation in BRCA-defective cells (Lemaçon et al., 2017; Mijic et al.,
2017; Taglialatela et al., 2017). The striking structural similarity
between the double-stranded end of regressed arms and
DSBs raises the intriguing possibility that DSB processing as
well as DSB signaling factors modulate stability and restart of
transiently stalled forks while they are remodeled into four-way
junctions.
Here we show that RNF168 and other factors of the DDR
cascade are recruited to replication factories and promote effi-
cient replication fork progression during unperturbed S phase
by preventing reversed fork accumulation at difficult-to-replicate
sequences and their processing by MRE11 nuclease. This alter-
native function of the DDR pathway requires RNF168-dependent
ubiquitination of H2A, suggesting that modifications of chro-
matin—which we found regularly assembled on the regressed
arms—promote efficient restart of endogenously formed
reversed forks and allow continuous fork progression. This novel
activity of the DDR pathway may provide alternative molecular
explanations to the complex phenotypes associated with DDR
defects in animal models and human cancer-prone syndromes.
RESULTS
RNF168 Localizes at Replication Factories in
Unperturbed Conditions
Although RNF168 activity has been extensively studied in the
context of DSB signaling, not much is known about its function
during unperturbed proliferation. We thought to retrieve some in-
formation from its subcellular localization in undamaged cells:
while RNF168 is rapidly recruited to DDR foci upon induction
of DSBs, showing an evident punctuate staining, its distribution
in unperturbed conditions is more heterogeneous within the cell
population. However, using a U2OS Flp-In T-REx system ex-
pressing FLAG-RNF168 to obtain controlled and detectable
expression of RNF168, we noted that in a subpopulation of cells
undergoing DNA replication, RNF168 partially co-localizes with
replication factories marked by PCNA foci (Figure 1A). We thus
investigated a possible association between RNF168 and
PCNA by performing co-immunoprecipitation and GST pull-
down experiments. Both biochemical approaches suggest that
PCNA and RNF168 interact in cells (Figure 1B). To further sub-
stantiate this observation, we set up a proximity ligation assay
(PLA) between RNF168 and PCNA, using both wild-type
FLAG-RNF168 and amutant form (referred as UBD), which is un-
able to bind ubiquitinated proteins and hence does not properly
localize to chromatin (Figure 1C) (Penengo et al., 2006; Pinato
et al., 2011). PLA analysis shows that RNF168 can be found in
close proximity to PCNA, while the UBD does not show any sig-
nificant association (Figure 1D). Moreover, to determine whether
RNF168/PCNA interaction occurs in a specific cell cycle phase,
we labeled cells with 5-ethynyl-20-deoxyuridine (EdU) to clearly
mark DNA synthesis, and we analyzed them by quantitative im-
age-based cytometry (QIBC) (Toledo et al 2013). This allowed us
to determine that the interaction between RNF168 and PCNA,
measured by PLA, mainly occurs during late S phase (Figures
1E, 1F, and S1). Using a similar experimental setting, we found
that the cell cycle distribution of the histone modification
H2AK15Ub, specifically generated by RNF168, correlates with
the distribution of PLA signal obtained for RNF168/PCNA (Fig-
ures 1G and 1H), indicating that RNF168 is active on chromatin
in this specific cell cycle phase. Together these data suggest a
potential role of RNF168 in DNA replication during unperturbed
S phase.
RNF168 Is Required for Proper DNA Replication in
Unperturbed Conditions
To test this hypothesis, we asked whether depletion of RNF168
has an impact on DNA synthesis, by measuring EdU incorpora-
tion in S phase using flow cytometry. We found that U2OS
shRNF168 cells show a marked reduction in the rate of EdU
incorporation uponRNF168 downregulation, indicating impaired
DNA synthesis (Figures 2A, S1A, and S1B). We next used the
DNA fiber spreading assay (Jackson and Pombo, 1998) to
investigate the effect of RNF168 depletion on replication fork
progression at single-molecule level. Strikingly, we found an
approximately 40% reduction in fork speed in unperturbed
RNF168-deficient cells, using either shRNA- or siRNA-mediated
downregulation with different target sequences (Figure 2B). This
reduction in fork speed involved the full population of replication
forks and was also visible upon shorter labeling times, albeit less
pronounced (Figure S2C). We next assessed whether this
reduced fork speed reflected frequent fork pausing by analyzing
forks diverging from the same replication origin. While in control
cells these forks move at similar rates, RNF168 depletion led
to marked sister fork asymmetry, indicating an increased fre-
quency of fork stalling upon RNF168 inactivation (Figure 2C).
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Interestingly, these effects on DNA replication were not accom-
panied by detectable global DDR activation, as revealed by over-
all nuclear levels of H2A.X phosphorylation (gH2A.X, Figure 2A,
right panel) and other canonical markers of checkpoint activation
(KAP1-, CHK1- and RPA-phosphorylation; Figure 2D). To further
exclude that this reduction in DNA synthesis upon RNF168
depletion is due to increased DNA damage, we performed a
DNA comet assay comparing RNF168-proficient with RNF168-
deficient cells. The two cell populations did not differ signifi-
cantly, while cells treated with the DNA damaging agent
camptothecin (CPT) expectedly show a marked accumulation
of chromosomal breaks (Figures 2E and S2D). These data
strongly suggest that the delayed fork progression observed in
RNF168-defective cells does not reflect detectable accumula-
tion of endogenous DNA damage and global DDR signaling.
We also used fibroblasts derived from aRIDDLE syndrome pa-
tient (RIDDLE cells) (Stewart et al., 2007),which contain inactivat-
ing mutations of the RNF168 gene in both alleles, and the same
cells complemented with HA-RNF168 as a reference (Stewart
et al., 2009). Importantly, both the reduced EdU incorporation
Figure 1. RNF168 Localizes at Replication Forks
(A) Representative images showing the partial co-localization of RNF168 and PCNA in U2OS Flp-In T-REx cells expressing doxycycline (Dox)-inducible FLAG-
RNF168 for 24 hr.
(B) Immunoblots validating the interaction of RNF168 and PCNA by coIP (left) or GST pull-down (right).
(C) Expression of FLAG-RNF168 wild-type (WT) and ubiquitin binding-deficient RNF168 (UBD) in Dox-inducible U2OS Flp-In T-REx cell lines.
(D) Representative images showing the proximity ligation assay (PLA) signal between FLAG-RNF168 (WT and UBD) and PCNA.
(E) Quantification of PLA accumulated intensity in sub-nuclear foci in S phase (EdU-positive) cells of the experiment described in Figure 1D. Similar cell numbers
were compared for the different conditions.
(F) Cell cycle distribution of PLA foci between wild-type RNF168 (WT and UBD) and PCNA.
(G and H) Cell cycle distribution of H2AK15Ub foci in EdU-positive cells.
All scale bars represent 10 mm. See also Figure S1.
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rate and the slow-down in fork speed as displayed by DNA fiber
track length are recapitulated in this experimental system and
are suppressed by exogenous RNF168 expression (Figures 2F
and S2E).
Unperturbed RNF168-Deficient Cells Display Elevated
Fork Reversal, Required for the Observed Fork Slowing
Recent evidence in human cells suggests that replication forks
are frequently undergoing remodeling into four-way junctions
(reversed forks) upon various types of exogenous replication
stress or at endogenous difficult-to-replicate loci (Follonier
et al., 2013; Neelsen and Lopes, 2015; Zellweger et al., 2015).
Intriguingly, the regressed arm at these structures exposes a
double-stranded DNA end, which strikingly resembles a DSB
and may thus implicate the function of DSB-responding factors.
To test the hypothesis that replication fork remodeling underlies
the involvement of DDR factors in unperturbed replication, we
employed an established electron microscopy (EM) protocol to
Figure 2. RNF168 Is Required for Efficient
DNA Replication in Unperturbed Conditions
(A) EdU and gH2AX flow cytometry intensity values
from S phase (EdU-positive) control (Dox) and
RNF168-depleted cells (+Dox). The intensity
values of 500 EdU-positive cells per sample were
extracted from the raw data and used for statistical
analysis. The level of RNF168 depletion is shown.
(B) DNA fiber spreading analysis of control cells
(siLUC, 72 hr) and cells depleted of RNF168 using
either an inducible shRNA (+Dox) or an siRNA of a
different sequence (siRNF168, 48 hr and 72 hr). A
labeling scheme and fibers of representative size
are shown for each condition in the top left panel.
The level of RNF168 depletion is shown.
(C) Representative images of a symmetric and an
asymmetric fork from U2OS shRNF168 cells.
Quantification of the sister fork ratio in RNF168-
proficient and -deficient cells is shown.
(D) Immunoblot analysis to follow checkpoint acti-
vation in control and RNF168-depleted cells using
the indicated antibodies. Cells treated with 1 mM
CPTserveaspositive control for fullDDRactivation.
(E) Quantification of the olive moment in control
and RNF168-depleted cells from a representative
neutral comet assay experiment. 1 mM CPT treat-
ment is used as a positive control for DNA double-
strand break formation. Mean value and standard
deviations are indicated as vertical lines for each
sample.
(F) RIDDLE patient fibroblasts (RIDDLE) and the
same cell line reconstituted with HA-RNF168 were
analyzed as in (A) and (B). RNF168 expression
levels were analyzed by immunoblotting. Asterisks
indicate unspecific signals.
****p value < 0.0001; whiskers, 10th–90th percen-
tile. See also Figure S2.
stabilize and visualize in vivo the architec-
ture of replication intermediates, in the
presence or absence of RNF168. Strik-
ingly, RNF168-deficient cells reproduc-
ibly showed a3-fold increased accumu-
lation of reversed forks during unperturbed replication,
compared to RNF168-proficient cells (Figures 3A and S3A–
S3D; Table S1A), suggesting that RNF168 affects the dynamics
of these remodeled replication intermediates. Reversed forks are
transient intermediates, and their accumulation upon genotoxic
treatments depends on the balance between promoting activ-
ities—such as the central recombinase RAD51 or the dsDNA
translocases SMARCAL1 and ZRANB3—and restart/resolution
factors, such as the RECQ1 helicase, which is negatively regu-
lated by PARP1-dependent PARylation (Berti et al., 2013; Neel-
sen and Lopes, 2015 and references therein). Importantly, we
found that preventing fork reversal by depleting either RAD51
or SMARCAL1 in RNF168-deficient cells completely restored
normal rates of fork progression during unperturbed S phase
(Figures 3B, 3C, S3E, and S3F), while depletion of ZRANB3—
reportedly dispensable for endogenous levels of fork reversal
(Vujanovic et al., 2017)—did not recapitulate the same effect
(Figures 3D and S3G). Analogously, PARP inhibition restored
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efficient fork progression in RNF168-defective cells in a RECQ1-
dependent manner (Figures 3E and S3H). Remarkably, PARP
inhibition in RIDDLE cells also fully rescued efficient fork pro-
gression to the levels observed upon RNF168 complementation
(Figures 3F and S3I). Altogether, these results indicate that repli-
cation fork reversal is a prerequisite for the defective fork pro-
gression observed upon RNF168 inactivation and suggest a
potential role for RNF168 in promoting reversed fork restart.
Furthermore, as RAD51 is strictly required for DSB repair, the
suppression of fork slowing upon RAD51 inactivation strongly
argues against accumulation of endogenous DSBs as the under-
lying mechanism of reduced fork progression in RNF168-defec-
tive cells. Along with the data in Figures 2D and 2E, this evidence
further supports a DSB-independent role for RNF168 during un-
perturbed S phase.
UpstreamandDownstreamDDRFactors AreEpistatic to
RNF168 for Its Replication Function
If the function of RNF168 in replication fork progression and re-
modeling truly reflects the formation of a double-stranded end
at regressed arms, we reckoned that depletion of other DDR fac-
tors should result in similar defects. To address this point, we
used various systems to target different DDR factors, alone or
in combination with RNF168 depletion. First, we used shRNA-
inducible U2OS cells to test the contribution of RNF8—which
acts upstream of RNF168 in the DDR pathway—to unperturbed
DNA replication. We found that, like RNF168, RNF8 depletion
leads to a reduced rate of DNA synthesis—measured by EdU
incorporation (Figure S4A)—and of replication fork progression
(Figure 4A). Importantly, co-depletion of RNF8 and RNF168 did
not lead to any further reduction in fork speed, suggesting that,
in analogy to the DSB response, the two factors are epistatic.
We obtained remarkably similar results in 53BP1 knockout
U2OS cells, which displayed a reduced rate of DNA synthesis
(Figure S4B) and fork progression that was not further exacer-
bated by concomitant RNF168 depletion (Figure 4B). Finally,
we analyzed the contribution of ATM, the apical kinase of the
DSB signaling pathway, responsible for RNF8/RNF168 recruit-
ment at DSBs. We tested fork progression in U2OS shRNF168
cells optionally treated with the ATM inhibitor KU55933 and/or
Figure 3. RNF168 Depletion Leads to Accumulation of Reversed Forks, Required for Fork Slowing
(A) Frequency of reversed replication forks in control and RNF168-depleted cells as found in three separate experiments by transmission electron microscopy
(EM). At least 70moleculeswere analyzed for each sample (***p value = 0.001, paired t test). An electronmicrograph of a representative reversed replication fork is
presented (P, parental duplex; D, daughter duplexes; R, regressed arm). RNF168 expression was analyzed by immunoblotting (*unspecific band).
(B–D) DNA fiber spreading analysis in control cells (siLUC, Dox) or in cells depleted of the indicated factors.
(E and F) DNA fiber spreading analysis investigating the effect of Olaparib treatment (Ola, 10 mM, 2 hr) on replication fork speed in RNF168-depleted cells
(siLUC, +Ola, +Dox) and cells co-depleted of RNF168 and RECQ1 (siRECQ1, +Ola, +Dox) and in RIDDLE and RIDDLE HA-RNF168 fibroblasts.
****p value < 0.0001; whiskers, 10th–90th percentile. See also Figure S3.
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doxycycline to conditionally downregulate RNF168. In parallel,
weanalyzed forkprogression in ataxia telangiectasia patient cells
(AT22iJE-T), which carry inactivating mutations in the ATM gene,
and in their complemented counterpart (Ziv et al., 1997). In both
systems, we observed that ATM activity is required for efficient
DNA replication: both pharmacological inhibition and genetic
inactivation lead to reduced DNA fork progression during unper-
turbed S phase, which is again epistatic to the effects observed
upon RNF168 inactivation (Figures 4C and 4D). Moreover, simi-
larly to the effects reported in RNF168-deficient cells (Figure 3A),
our EM analysis revealed a 2.5- to 3.5-fold accumulation of
reversed forks in RNF8- and 53BP1-deficient U2OS cells, as
well as upon ATM inhibition (Figure 4E; Table S1B–S1D). Impor-
tantly, BRCA1 depletion had only a marginal effect on replication
fork progression, which was not epistatic to RNF168 depletion
(Figure S4C), suggesting that RNF168’s role in replication is inde-
pendent of the downstream HR pathway.
Although these data clearly indicate that the ATM/RNF8/
RNF168/53BP1 signaling pathway is required for efficient DNA
replication in unperturbed S phase, we were puzzled by the
absence of detectable checkpoint activation under these condi-
tions (Figures 2A and 2D). We thus carefully monitored H2A.X
phosphorylation throughout the cell cycle by QIBC analysis in
U2OS shRNF168 cells. We found that cells in middle and late
S phase do show detectable gH2A.X foci even in the absence
of exogenous treatments (Figures 4F and S4D). This gH2A.X
signal is specific and not cell line dependent, as it was readily
detected also in RPE-1 cells but was abolished by H2A.X
replacement with a non-phosphorylatable version (H2A.X-
S139A; Figure S4E). Furthermore, this endogenous gH2A.X
signal is largely reduced upon treatment with both ATR and
ATM inhibitors (Figure 4F). Thus, despite undetectable global
DDR activation (Figures 2A–2D), local ATR/ATM-mediated
H2A.X phosphorylation detectably increases during cell cycle
progression, reaching a peak in late S phase and correlating
with other marks of activation of the DDR cascade (Figures 1E
and 1H). Accordingly, blocking this signaling cascade down-
stream by RNF168 depletion did not affect global H2A.X phos-
phorylation, but induced local accumulation of gH2A.X in
these endogenous foci (Figures 2A, 4F, 4G, and S4F). Similar
conclusions could be drawn by iPOND (Sirbu et al., 2013), by
which we found detectable levels of H2A.X phosphorylation
directly at replication forks, which were increased upon
RNF168 depletion (Figure 4H). Finally, we tested whether the
impairment of endogenous H2A.X phosphorylation resulted in
replication phenotypes similar to those observed upon other
DDR defects. Using untransformed RPE-1 cells expressing
either wild-type H2A.X or its phosphorylation mutant (S139A;
Figure S4E), we found that—similarly to all other tested DDR de-
fects (Figures 4A–4E)—defective H2A.X phosphorylation leads
to accumulation of reversed forks and impaired replication fork
progression and that the latter defect is epistatic to ATM inhibi-
tion (Figures 4I and 4J; Table S1E). Together, these results sug-
gest that, despite undetectable global activation of the DDR,
local H2A.X phosphorylation during unperturbed S phase en-
gages classical DDR factors in controlling fork remodeling and
promoting efficient fork progression.
Reduced Fork Speed upon RNF168 Depletion Depends
on Nucleolytic Processing
Although fork reversal was proposed to assist fork integrity and
restart upon replication stress (Neelsen and Lopes, 2015), it was
also recently shown to trigger MRE11-dependent degradation of
stalled forks under certain genetic perturbations, which medi-
ates the chemosensitivity of BRCA-defective cells (Lemaçon
et al., 2017; Mijic et al., 2017; Ray Chaudhuri et al., 2016). We
thus tested whether MRE11-dependent degradation is also
implicated in the defects in fork progression and architecture
observed upon interference with the DDR pathway. Using mirin
as a well-characterized inhibitor of MRE11 nuclease activity at
replication forks (Schlacher et al., 2011), we found that MRE11
inhibition significantly restored replication fork progression in
all tested systems of RNF168-, RNF8-, 53BP1-, ATM-, and
gH2A.X-depletion/inactivation conditions (Figures 5A–5F).
These data suggest that the fork slowing observed in all these
conditions reflects increased MRE11 activity or accessibility to
de-protected forks, leading to nucleolytic processing of newly
synthesized DNA. In light of the limited processivity reported
for cellular nucleases, the reduced track length observed upon
DDR inactivation is unlikely to purely reflect degradation of
nascent DNA. In fact, it may also result from impaired DNA syn-
thesis while forks are engaged in unscheduled processing, ulti-
mately leading to temporary fork stalling. Moreover, the partial
rescue of fork speed observed uponmirin treatmentmight reflect
the redundant action of nucleases other than MRE11 (Lemaçon
et al., 2017) at replication forks destabilized by inactivation of the
Figure 4. Upstream and Downstream DDR Factors Share the Replication Function of RNF168 and Are Epistatic to It
(A and B) Statistical analysis of IdU track length measurements from a DNA fiber spreading experiment performed in cells with different genetic contexts, as
indicated.
(C and D) DNA fiber spreading analysis of RNF168-proficient or -deficient cells (C) after pre-treating with an ATM inhibitor (ATMi) for 1 hr before labeling, of the
ataxia telangiectasia patient fibroblast cell line AT22IJE-T carrying an empty expression vector (pEBS7), and of the same cell line expressing recombinant
ATM (YZ5).
(E) Frequency of reversed replication forks observed by EM analysis in control cells and cells subjected to the depletion or inhibition of the indicated DDR factors.
(F) Quantification of gH2A.X accumulated intensity in sub-nuclear foci in different cell cycle phases in pre-extracted cells (see STAR Methods), treated as
indicated.
(G) Representative cell cycle distribution of gH2A.X accumulated intensity in sub-nuclear foci of control and RNF168-depleted cells.
(H) Immunoblot showing gH2A.X protein levels in iPOND experiment in control and RNF168-depleted cells.
(I) DNA fiber spreading analysis in WT and H2A.X-S139A cells under untreated conditions (NT) or upon ATMi.
(J) Frequency of reversed replication forks in WT and H2A.X-S139A cells as observed by EM analysis. The numbers in brackets in E and L indicate the total of
analyzed molecules, and the values written above the columns indicate the relative reversal frequencies. Results of an additional independent experiment are
reported in Table S1. ****p value < 0.0001; whiskers, 10th–90th percentile. See also Figure S4.
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DDRpathway. As reported (Mijic et al., 2017), mirin treatment per
se did not affect the frequency of reversed forks. Surprisingly—
and differently from what was reported at hydroxyurea-stalled
forks upon BRCA defects (Lemaçon et al., 2017; Mijic et al.,
2017)—mirin treatment in unperturbed RNF8-, RNF168-, or
53BP1-defective cells invariably led to further marked accumu-
lation of reversed forks (Figures 5G, S5A, and S5B; Tables
S1A–S1C). In both the presence and the absence of mirin,
reversed forks accumulating upon RNF8, RNF168, or 53BP1
inactivation frequently exposed extended ssDNA stretches,
further suggesting that inactivation of the DDR pathway pro-
motes deregulated regressed arm resection in unperturbed con-
ditions (Figures 5G, S5A, and S5B).
It is seemingly counterintuitive that inhibiting MRE11 activity
rescues fork speed but leads to further accumulation of reversed
forks upon inactivation of various DDR factors. However, it is
important to note that DNA fiber spreading measures the rate
of fork progression over a distance, while EM analysis provides
snapshots of the most persisting intermediates along the path
of active forks (Vindigni and Lopes, 2017). As discussed above,
MRE11-dependent degradation of transiently reversed forks
may counteract DNA synthesis under conditions of defective
DDR, leading to slow fork progression as a net effect. Impairing
this degradation would prevent fork backtracking and promote
continued fork progression via resection-independent restart of
reversed forks. However, the overload and/or the intrinsic slow-
ness of this restart mechanism uponMRE11 inhibition may force
forks to spend a higher fraction of time in the reversed state, ex-
plaining our EM observations. The marked accumulation of
reversed forks observed by inactivation of MRE11 and the
DDR pathway is particularly striking, considering that these cells
are not exposed to exogenous sources of genotoxic stress. This
suggests that the RNF168 pathway is essential to counteract
regressed arm resection and to provide efficient restart of
endogenously reversed forks, preventing their accumulation
during unperturbed S phase.
RNF168-Dependent Histone H2A Ubiquitination Is
Required for Efficient DNA Replication
A key event of the DSB signaling pathway is the ubiquitination of
histone H2A on the N-terminal site K13/K15 promoted by
RNF168 (Gatti et al., 2012; Mattiroli et al., 2012), which is
required for the activation of the downstream signaling cascade,
being directly recognized by 53BP1 (Fradet-Turcotte et al.,
2013). Hence, we asked whether this histone mark is also essen-
tial for RNF168 function in DNA replication. To address this point,
we took advantage of a single point mutation in RNF168 (R57D),
which maintains the ubiquitinating capability but specifically im-
pairs the ubiquitination of histone H2A (Mattiroli et al., 2012). We
generated Flp-In T-REx U2OS stable cell lines expressing FLAG-
RNF168 wild-type, UBD, and R57D—all designed to be resistant
to siRNAs targeting endogenous RNF168—confirmed that they
Figure 5. Reduced Fork Speed upon RNF168/RNF8/53BP1/ATM Depletion Depends on MRE11-Dependent Nucleolytic Processing
(A–F) DNA fiber spreading analysis of the effect of mirin treatment on the replication fork speed in different backgrounds, as indicated, or in combination with
ATMi (D).
(G) Frequency of reversed replication forks observed by EM analysis in RNF168-proficient versus -deficient cells left untreated or treated with mirin. The re-
gressed arms of reversed forks were inspected for single-stranded DNA stretches (ssDNA). The percentage of partially single-stranded regressed arms is
indicated in gray and the percentage of completely single-stranded regressed arms in black. ****p value < 0.0001, ***p value 0.0002; whiskers, 10th–90th
percentile. See also Figure S5 and Tables S1B and S1C.
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had normal cell cycle progression, and used them to perform
complementation experiments (Figures S6A–S6C). We were
able to restore efficient fork progression in siRNF168-depleted
cells by expressing wild-type RNF168 but not with UBD nor
with R57D mutants, clearly indicating that not only the proper
localization of RNF168 but also its specific activity toward his-
tone H2A are required to mediate efficient fork progression dur-
ing unperturbed S phase (Figure 6A).
Regular Nucleosome Deposition Occurs on
Regressed Arms
Next, we reasoned that if the RNF168-mediated ubiquitination of
H2A is required for efficient DNA replication via controlled restart
of reversed forks, wewould expect its targets (i.e., nucleosomes)
to be present on the fourth, regressed arms of these intermedi-
ates. To address this important point, we performed in vivo
psoralen crosslinking, coupled to EM analysis in denaturing con-
ditions. As psoralen only intercalates in linker DNA between nu-
cleosomes, this analysis reveals the nucleosomal organization of
replicating molecules as a string of single-stranded bubbles
separated by psoralen crosslinks, while non-chromatinized
DNA (e.g., mitochondrial DNA, Figure S6D) appears as uniformly
crosslinked DNA (Lucchini and Sogo, 1995). To verify that
reversed forks could be confidently identified by denaturing
EM analysis, we analyzed two different conditions of reversed
fork accumulation—i.e., RNF168 depletion and topoisomerase
I poisoning by CPT (Ray Chaudhuri et al., 2012)—and confirmed
that their frequency was very similar in standard (native) and
denaturing EM analysis (Figure S6E). We then carefully in-
spected the appearance of the identified regressed arms and
noticed that single-stranded bubbles could be readily detected
on all reversed replication forks found (Figure 6B) and had stan-
dard size (150 bp per nucleosome) and periodicity as detected
on parental and replicated DNA (Figures 6C, S6F, and S6G).
These data strongly suggest that, despite their transient nature,
regressed arms are readily chromatinized and display standard
nucleosomal organization, thereby offering targets for DDR-
mediated modifications.
RNF168-Deficient Cells Show Defects in Replicating
Repetitive Sequences and Accumulate Chromosomal
Abnormalities in Mitosis
Taken together, the replication defects described above upon
inactivation of RNF168 and other DDR factors could be ex-
plained by a role of these proteins in replicating genomic regions
that are intrinsically difficult to replicate and are thus particularly
prone to fork reversal. Repetitive sequences, notably abundant
in the human genome, are known to induce replication fork slow-
ing (Neil et al., 2017). Recently, expanded GAA/TTC sequences
were shown to undergo frequent fork reversal under unperturbed
conditions by bidimensional electrophoresis (2D gels) and EM
analysis of chromatinized, SV40-based plasmids (Follonier
et al., 2013). Transfecting this plasmid system in U2OS
shRNF168 cells, we verified that control plasmids were repli-
cated with similar efficiency in the presence or absence
of RNF168 (Figure S7A). However, when the transfected plas-
mids contained expanded GAA/TTC regions, additional signals
were readily detected by 2D gels, such as a spot on the Y arc
due to fork pausing at repeats, a ‘‘X-spot’’ corresponding
to triplex-mediated post-replicative junctions, and a spike
signal—departing from the pausing spot and reaching just above
the X-spot—which was shown to be highly enriched in forks
reversed at the repetitive sequence (Figure 7A) (Follonier et al.,
2013). Strikingly, by accurate quantification of 2D gels (Fig-
ure S7B) in two independent experiments, we reproducibly
observed that the signal corresponding to reversed forks was
specifically increased upon conditional RNF168 depletion (Fig-
ures 7A and S7C). Along with the data in Figure 3A, these results
strongly suggest that RNF168 is required to prevent reversed
fork accumulation at endogenous difficult-to-replicate regions,
presumably by promoting effective reversed fork restart. In line
with these replication problems, we observed that prolonged
(1 week) RNF168 depletion in U2OS shRNF168 cells, as well
as permanent RNF168 inactivation in RIDDLE cells, are associ-
ated with increased chromosome abnormalities in mitosis,
mostly visible as regions of decondensed chromatin alongmeta-
phase chromatids (Figures 7B and S7D–S7F). The effect is exac-
erbated when DNA replication is challenged by treating cells with
low-dose aphidicolin (Aph, Figure 7C). Similar observations have
been reported upon other genetic perturbations increasing
endogenous replication stress and bona fide reflect genomic re-
gions where replication is not complete upon entry into mitosis
(Bhowmick and Hickson, 2017).
DISCUSSION
We provide here several lines of evidence that well-established
DDR factors of the RNF168 pathway play a crucial role to assist
the replication process in the absence of any exogenous geno-
toxic stress. A link between this pathway and endogenous repli-
cation stress was proposed while describing 53BP1 nuclear
bodies, as these G1 phase-specific nuclear accumulations of
53BP1 were linked to unresolved replication stress inherited
from the previous S phase. However, these structures were sug-
gested to arise via mitotic processing of these residual interme-
diates into DSBs, invoking the classical function of this pathway
in DSB signaling and repair (Lukas et al., 2011). Similarly, Rad9/
53BP1—along with its antagonistic partner, BRCA1—was also
recently involved in mechanisms of stalled fork processing and
restart upon genotoxic treatments (Her et al., 2018; Villa et al.,
2018; Xu et al., 2017), but a potential role of DSB signaling factors
at replication forks during unperturbed S phase has remained
unexplored.
We now show that these factors are required for efficient repli-
cation fork progression even in the absence of exogenous stress
and detectable DNA breakage or DSB signaling, identifying a
new crucial role for this pathway in addition to its established
role in the DSB response. Four important lines of evidence sup-
port a specific role for the RNF168-associated DDR pathway
during unperturbed replication, independent of DSB formation:
(1) RNF168 co-localizes and physically interacts with PCNA at
a subset of replication factories in unperturbed conditions, which
are not associated with detectable DDR activation or physical
evidence of DNA breaks; (2) the replication function of RNF168
requires specific ubiquitination of histone H2A (H2AK15Ub),
which is indeed cytologically detectable during unperturbed
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Figure 6. RNF168Ubiquitin Ligase Activity onHistoneH2A Is
Required for Efficient DNA Replication
(A) DNA fiber spreading analysis of replication fork progression rate in
U2OS Flp-In T-REx cell lines conditionally expressing siRNA-resis-
tant forms of RNF168WT and the indicated mutants. All four cell lines
were depleted of endogenous RNF168 by siRNA transfection
(siRNF168) 60 hr before Dox induction.
(B) Representative electron micrograph of a denatured reversed
replication fork from U2OS cells depleted of RNF168 using an
inducible shRNA (P, parental duplex; D, daughter duplexes; R, re-
gressed arm). The white scale bar equals 200 nm.
(C) Frequency distribution of the single-stranded bubble size on the
regressed arm as observed by EM of denatured reversed replication
forks from cells treated with 50 nM CPT or from RNF168-depleted
cells. Similar distributions were observed on the parental and the two
daughter strands of the same molecules and are depicted in Figures
S6E and S6F. ****p value < 0.0001; whiskers, 10th–90th percentile.
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S phase; (3) even though global DDR activation is undetectable
in unperturbed S phase, local ATR/ATM-dependent H2A.X
phosphorylation can be monitored—especially in late S
phase—and plays a key role upstream of RNF168 activation in
mediating efficient replication fork progression; (4) RNF168 is
required to limit the accumulation of unusual replication interme-
diates at a prototype of difficult-to-replicate regions—i.e.,
expanded GAA repeats—previously shown to induce transient
fork slowing and remodeling.
These findings are reminiscent of the surprising evidence that
key DNA repair factors—such as BRCA factors and Fanconi ane-
mia proteins—play a genetically separable role in replication fork
protection, which emerged as a key determinant of the chemo-
sensitivity observed in BRCA-defective tumors (Ray Chaudhuri
et al., 2016; Schlacher et al., 2012). Several groups reported
that this clinically relevant, unscheduled nucleolytic degradation
observed in BRCA-defective cancer cells is triggered by the re-
modeling of stalled forks into four-way junctions (Lemaçon et al.,
2017; Mijic et al., 2017; Taglialatela et al., 2017). Analogously,
Tel1—the yeast ATM ortholog—was recently reported to protect
against degradation forks reversed upon topoisomerase I inhibi-
tion (Menin et al., 2018). Remarkably, usingmultiple genetic tools
to interfere with replication fork remodeling (i.e., PARP inhibition
and RAD51, SMARCAL1, or RECQ1 depletion), we found that
the defects observed during unperturbed replication upon inac-
tivation of RNF168 strictly depend on replication fork reversal. In
light of the striking similarity between DSBs and double-
stranded ends exposed at regressed arms, we propose that
DSB signaling factors are recruited to remodeled replication
forks and participate in modulating stability and restart of tran-
siently stalled forks.
An important implication of our EM observations is that even
during unperturbed S phase, a surprisingly high number of repli-
cation forks undergo reversal, imposing efficient fork restart
mechanisms to prevent massive accumulation of reversed forks.
Several chromosomal regions have been identified as ‘‘difficult-
to-replicate,’’ be it because of their repetitive nature, their
propensity to form secondary structures, and/or their active tran-
scription (Glover et al., 2017; Neil et al., 2017). Difficult-to-repli-
cate regions tend to be replicated toward the end of S phase
(Glover et al., 2017); interestingly, all marks of recruitment/acti-
vation of the RNF168 pathway—i.e., local gH2A.X, RNF168/
PCNA proximity, and H2AK15Ub (Pellegrino et al., 2017)—are
also enriched in late S phase. However, repetitive DNA repre-
sents up to 50% of all human genome, which may explain why
most replication forks experience delayed progression upon
inactivation of the DDR pathway during the standard labeling
time of a fiber spreading experiment. It is likely that a large frac-
tion of replication forks frequently undergo transient remodeling
and require an active DDR pathway to efficiently drive fork
Figure 7. RNF168-Deficient Cells Show Defects in Replicating Repetitive Sequences, Resulting in Chromosomal Abnormalities
(A) Representative 2D gel analysis of an EcoRI-digested SV40-based plasmid containing 90 GAA/TTC repeats 48 hr after transfection into control and RNF168-
depleted cells. Signals corresponding to different categories of replication intermediates were quantified as described in Figure S5A and depicted as bar plots for
both samples. The graph on the right side explains the migration pattern of different replication intermediates of the used plasmid. The asterisk marks the so-
called ‘‘X-spot,’’ representing triplex-mediated junctions between replicated duplexes, reported to accumulate after replication of expanded GAA/TTC repeats
(Follonier et al., 2013).
(B and C) Metaphase spreads to detect chromosomal aberrations in control and long-term RNF168-depleted cells (7 days) untreated (B) or treated with low dose
of aphidicolin (C). Representative images are included. The graphs on the right depict the number of observed chromosomal abnormalities from three separate
experiments.
See also Figure S7.
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protection and restart. In that respect, RNF168 activation may
consistently occur at replication forks, but the associated marks
may become cytologically detectable only at chromosomal
locations where fork pausing and reversal is less transient,
i.e., at endogenous difficult-to-replicate regions, and/or where
they inherently cluster, e.g., at condensed heterochromatic
regions.
Another important implication of our data is that frequent,
albeit transient, accumulation of double-stranded ends during
fork remodeling implies an intrinsic risk of DDR activation, posing
very similar issues to those extensively characterized at telo-
meres (Maciejowski and de Lange, 2017). However, even in ge-
netic conditions that prevent a rapid turnover of reversed forks
and thus lead to their accumulation and processing, we
observed no detectable evidence of global DDR activation. It
will be an interesting avenue of future research to clarify whether,
similarly to telomeres, active mechanisms have evolved to finely
control DDR activation from these endogenous DNA ends, which
are associated with every unperturbed S phase and which
certainly exceed telomeres in numbers. It is very likely that,
despite the involvement of several classical DSB signaling fac-
tors in replication fork transactions, the DDR pathway may
have specificmechanisms of signal amplification/limitation while
playing its key role in unperturbed replication, in order to avoid
interference with cell cycle progression. As shown here, detec-
tion of local and transient DDR activation during fork remodeling
requires more refined experimental conditions than those exten-
sively characterized in response to exogenous DNA damage.
How is the DDR pathway modulating the restart of reversed
forks, limiting their accumulation? Our EM evidence suggests
that inactivation of this pathway shifts the equilibrium of tran-
siently stalled forks toward a reversed state and promotes nucle-
olytic processing of regressed arms, which at least partially limit
accumulation of these structures in DDR-defective cells. As
reversed fork restart was also shown to occur via both nucleo-
lytic and non-nucleolytic pathways (Berti et al., 2013; Neelsen
and Lopes, 2015), it is tempting to speculate that recruitment
of these factors to the DNA end at regressed arms may limit ac-
cess to nucleases. This may be achieved by direct protection of
the end and/or by promoting an alternative pathway of reversed
fork restart—e.g., via RECQ1-dependent branch migration—
which does not implicate DNA end resection. Alternatively, and
in analogy with its role in HR-mediated DSB repair (Smeenk
and Mailand, 2016), RNF168-dependent chromatin ubiquitina-
tion may finely control regressed arm resection and promote
RAD51-mediated fork protection and restoration mechanisms.
Indeed, besides the well-established competition of 53BP1
and BRCA1 for DSB repair mechanism (Bunting et al., 2010),
our data highlight the importance of ubiquitin-dependent
53BP1 functional recruitment in finely regulating the productive
outcome of the recombination process, most likely by limiting
unscheduled double-stranded end processing (Ochs et al.,
2016). It will be important to explore specific protein partners
of DDR factors during unperturbed S phase to gain mechanistic
insight into the alternative function of these factors in replication.
The observation that regressed arms readily assemble nucle-
osomes is important and unexpected for structures that are
inherently meant to be transient, as effective processing of these
arms during fork restart would need nucleosome eviction. How-
ever, we reckon that nucleosome deposition on all DNA
branches at the replication fork is passively accomplished, as
it would be mechanistically difficult for the nucleosome deposi-
tion apparatus to distinguish regressed arms from standard
replicated duplexes. Moreover, it would also be risky for the cells
to have non-chromatinized DNA in proximity to paused replica-
tion forks, as this would increase the risk of unscheduled nucle-
olytic processing and chromosomal rearrangements. In fact, the
evidence that nucleosomes are deposited on regressed arms—
which were recently identified as entry points for fork degrada-
tion—suggests that histone modifications may be crucial
determinants for the necessary equilibrium between DNA syn-
thesis and degradation that assists efficient fork pausing and
restart. This is in keeping with growing evidence that histone
methylases such as MLL3/4 and SETD1A and chromatin remod-
elers such as CHD4 play critical roles in modulating fork acces-
sibility by active nucleases, such as MRE11 (Higgs et al., 2018;
Ray Chaudhuri et al., 2016). It will be a challenging but crucial
task for future research to establish methods to specifically
isolate and analyze the dynamic composition of nascent chro-
matin at regressed arms. Besides assessing the direct binding
of DSB processing and signaling factors, such experiments
promise to reveal the complex cellular apparatus, as well as
epigenetic modifications, modulating reversed fork stability
and restart. These studies may significantly help to shed light
on mechanisms of genome instability during cellular proliferation
and on patient-specific responses to chemotherapeutic treat-
ments interfering with replication.
Overall, this work directly involves key DDR factors in the mo-
lecularmechanisms promoting efficient replication during unper-
turbed conditions. Some of the phenotypes associated with
inactivation of these factors—such as immunodeficiency and
radiosensitivity—are clearly linked to their role in the DSB
response (Jackson and Bartek, 2009). However, it is tempting
to speculate that other phenotypes associated with DDR inacti-
vation at cellular levels—i.e., chromosomal instability—or in spe-
cific DDR-defective animal models and patients may also reflect
the alternative role in unperturbed replication that we propose
here for this signaling cascade.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
anti-gH2AX antibody (flow cytometry) EMD Millipore Cat# 05-636; RRID: AB_309864
anti-gH2AX antibody (QIBC) Cell Signaling Technology Cat# 9718; RRID: AB_2118009
anti-H2AX antibody Abcam Cat# ab11175; RRID: AB_297814
anti-RPA pS4/S8 Bethyl Laboratories Cat# A300-245A; RRID: AB_210547
anti-KAP1 pS824 Behyl Laboratories Cat# A300-767A; RRID: AB_669740
anti-KAP1 Bethyl Laboratories Cat# A300-274A; RRID: AB_185559
anti-RPA32 Bethyl Laboratories Cat# A300-244A; RRID: AB_185548
anti-mouse Alexa 546 Life Technologies Cat# A11003; RRID: AB_141370
anti-rabbit Alexa 488 Life Technologies Cat# A11008; RRID: AB_143165
anti-rabbit Alexa 555 Life Technologies Cat# A21428; RRID: AB_141784
anti-mouse Alexa 647 Life Technologies Cat# A21235; RRID: AB_141693
anti-mouse Alexa 488 (Fibers) Life Technologies Cat# A10011; RRID: AB_2534069
anti-mouse Alexa 488 (Immunofluorescence) Immunological Sciences Cat# IS-20010
anti-rat Cy3 Jackson ImmunoResearch Cat# 712-165-513; RRID: AB_2340669
anti-CHK1pS345 Cell Signaling Technology Cat# 2348; RRID: AB_331212
anti-FLAG rabbit Sigma-Aldrich Cat# F7425; RRID: AB_439687
anti-FLAG mouse M2 clone Sigma-Aldrich Cat# F1804; RRID: AB_262044
anti-CHK1 Santa Cruz Cat# sc-8408; RRID: AB_627257
anti-Rad51 Santa Cruz Cat# sc-8349; RRID: AB_2253533
anti-PCNA PC10 Santa Cruz Cat# sc-56; RRID: AB_628110
anti-RNF168 R. Freire lab Instituto de Tecnologı́as
Biomédicas, Tenerife, Spain
N/A
anti-RNF8 R. Freire lab Instituto de Tecnologı́as
Biomédicas, Tenerife, Spain
N/A
anti-GAPDH Millipore Cat# MAB374; RRID: AB_2107445
anti-mouse HRP conjugate GE Healthcare Cat# NA931V
anti-rabbit HRP conjugate GE Healthcare Cat# NA934V
Rat anti-BrdU/CldU Abcam Cat# ab6326; RRID: AB_305426
anti-53BP1 Abcam Cat# ab36823; RRID: AB_722497
anti-BrdU/IdU BD Biosciences Cat# 347580; RRID: AB_10015219
anti-RECQ1 Sigma-Aldrich Cat# ABC1428
anti-B tubulin Santa Cruz Cat# sc-9104; RRID: AB_2241191
anti-H2A K15ub Z. Zhang lab Mayo Clinic College of
Medicine, Rochester, Minnesota, USA
N/A
Chemicals, Peptides, and Recombinant Proteins
4,50,8-trimethylpsoralen Sigma-Aldrich Cat# 512-56-1
2-Mercaptoethanol Sigma-Aldrich Cat# M3148
jetPRIME Polyplus transfection Cat# 114-01
Doxycycline hyclate Sigma-Aldrich Cat# D9891
5-Chloro-20-deoxyuridine Sigma-Aldrich Cat#C6891
5-Iodo-20-deoxyuridine Sigma-Aldrich Cat#I7125
Proteinase K, recombinant, PCR Grade Sigma-Aldrich Cat# 03115852001
Blasticidin InvivoGen Cat# ant-bl-05
Puromycin InvivoGen Cat# ant-pr-05
(Continued on next page)
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Hygromycin B Gold InvivoGen Cat# ant-hg-05
Olaparib Selleckchem Cat# S1060
KU-55933 (ATMi) Sigma-Aldrich Cat# SML1109
Mirin Sigma-Aldrich Cat# M9948
PvuII high fidelity New England Biolabs Cat# R3151S
pOG44 Flp-Recombinase Expression Vector Thermo Fisher Cat# V600520
VECTASHIELD Antifade Mounting Medium Vector Laboratories Cat# H-1200
Prolong Gold antifade Mountant Thermo Fisher Cat# P36930
Nocodazole Sigma-Aldrich Cat# M1404
EcoRI BioLabs Cat# R0101S
DpnI BioLabs Cat# R0176L
RO-3306 Sigma-Aldrich Cat# SML0569-5MG
Aphidicolin Sigma-Aldrich Cat# A0781-5MG
Colcemid Thermo Fisher Cat# 15210040
XmnI BioLabs Cat# R0194L
Zeta-probe membranes Bio-Rad Cat# 1620153
Critical Commercial Assays
Click-iT EdU Alexa Fluor 488 Flow Cytometry
Assay Kit (flow cytometry)
Thermo Fisher Scientific Cat# C10425
Click-iT EdU Alexa Fluor 647 Imaging Kit
(Immunofluorescence)
Thermo Fisher Scientific Cat# C10340
Comet Assay 2 Well ES Unit with Starter Kit Trevigen Cat# 4250-050-ESK
QIAGEN-tip 20 Plasmid Mini Kit QIAGEN Cat# 10023
Amicon ultra 100K membrane size-exclusion
columns
Millipore Cat# UFC510096
Duolink In Situ Orange Starter Kit Mouse/Rabbit Sigma-Aldrich Cat# DUO92102
Mitochondrial DNA Isolation Kit Abnova Cat# KA0895
QIAprep Spin Miniprep kit QIAGEN Cat# 27104
Deposited Data
Raw imaging data This paper https://doi.org/10.17632/hkjz8w9c6p.1
Experimental Models: Cell Lines
U2OS ATCC HTB-96
53BP1 WT U2OS Steve Jackson lab Wellcome Trust/
Cancer Research UK
N/A
53BP1 KO U2OS Steve Jackson lab Wellcome Trust/
Cancer Research UK
N/A
U2OS shRNF168 Jiri Lukas lab University of Copenhagen
Denmark
N/A
U2OS shRNF8 Niels Mailand lab University of
Copenhagen Denmark
N/A
RIDDLE patient fibroblasts Grant Stewart lab University of
Birmingham UK
N/A
RIDDLE patient fibroblasts HA-RNF168 Grant Stewart lab University of
Birmingham UK
N/A
RPE H2AX S139A Steve Jackson lab Wellcome Trust/
Cancer Research UK
N/A
RPE WT (Matched with H2AX S139A) Steve Jackson lab Wellcome Trust/
Cancer Research UK
N/A
U2OS ZRANB3 wild type control David Cortez lab Vanderbilt
University USA
N/A
(Continued on next page)
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact Lorenza
Penengo (penengo@imcr.uzh.ch).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
U2OS shRNF168
Human osteosarcoma U2OS cell line expressing a doxycycline inducible shRNA against RNF168 (kindly provided by J. Lukas) was
cultured in DMEM supplemented with 10%FBS, 100 U/mL penicillin, 100 mg/mL streptomycin 1 mg/mL puromycin and 5 mg/mL blas-
ticidin in an atmosphere containing 6%CO2 at 37
C. shRNA expression was induced by adding doxycycline to the growth media at a
final concentration of 1 mg/mL for 96 hr.
U2OS shRNF8
Human osteosarcoma U2OS cell line expressing a doxycycline inducible shRNA against RNF8 (kindly provided by N. Mailand) was
cultured in DMEM supplemented with 10%FBS, 100 U/mL penicillin, 100 mg/mL streptomycin 1 mg/mL puromycin and 5 mg/mL blas-
ticidin in an atmosphere containing 6%CO2 at 37
C. shRNA expression was induced by adding doxycycline to the growth media at a
final concentration of 1 mg/mL for 96 hr.
U2OS 53BP1 KO and matching WT U2OS
CRISPR/Cas9 generated 53BP1 KO and the WT U2OS cell line from which they originate (both kindly provided by S. Jackson) were
cultured in DMEM supplemented with 10% FBS, 100 U/mL penicillin, and 100 mg/mL streptomycin in an atmosphere containing
6% CO2 at 37
C.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
U2OS ZRANB3 knock out (clone 38) David Cortez lab Vanderbilt
University USA
N/A
AT22IJE-T (pEBS7) Yossi Shiloh lab Tel Aviv University Israel N/A
AT22IJE-T (YZ5) Yossi Shiloh lab Tel Aviv University Israel N/A
Oligonucleotides
siRAD51: GACUGCCAGGAUAAAGCUUdTdT Microsynth N/A




siSmarcal1: AAGCAAGGCCCAUCCCAAAdTdT Microsynth N/A
siBRCA1: GGAACCUGUCUCCACAAAGdTdT Microsynth N/A
SMART pool against human RECQ1 Dharmacon NM_032941
Software and Algorithms
GraphPad Prism7 for MAC OS X GraphPad Software https://www.graphpad.com/
ImageJ64 (DNA fiber length analysis and EM data) ImageJ Software https://imagej.nih.gov/ij/
Fiji (Comets) ImageJ Software https://imagej.nih.gov/ij/
FlowJo (Facs data analysis) FlowJo Software https://www.flowjo.com/
Attune Nxt (flow cytometry data acquisition) Attune NxT Software https://www.thermofisher.com/
Olympus ScanR Image Analysis Software
Version 2.5.1 (QIBC data analysis)
Olympus Corporation https://www.olympus-ims.com/
en/microscope/software/
Spotfire data visualization software
version 5.0.0 (QIBC data analysis)
TIBCO Software Inc. https://spotfire.tibco.com/
FusionCapt Advance Solo 7 17.02 control
and analysis software for chemiluminescence
detection (used for western blot)
Vilber Lourmat http://www.vilber.de/
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RIDDLE and RIDDLE HA-RNF168
RIDDLE patient fibroblasts and the same cell line reconstituted with HA-RNF168 (both kindly provided byG. Stewart) were cultured in
DMEM supplemented with 10% FBS, 100 U/mL penicillin, and 100 mg/mL streptomycin in an atmosphere containing 6% CO2
at 37C.
U2OS
Human osteosarcoma U2OS cells were cultured in DMEM supplemented with 10% FBS, 100 U/mL penicillin, and 100 mg/mL strep-
tomycin in an atmosphere containing 6% CO2 at 37
C.
AT22IJE-T cell lines
Ataxia-telangiectasia fibroblast cell line AT22IJE-T carrying an empty expression vector (pEBS7) and the same cell line expressing
recombinant ATM (YZ5) (kindly provided by Y. Shiloh) were cultured in DMEM supplemented with 20% FBS, 100 U/mL penicillin, and
100 mg/mL streptomycin in an atmosphere containing 6% CO2 at 37
C.
U2OS Flp-In T-REx cell lines
The four cell lines for the doxycycline inducible expression of wild-type or mutant RNF168 presented in this manuscript (EV, WTres,
R57Dres and UBDres) were generated by transfecting 160,000 U2OS Flp-In T-REx cells (kindly provided by D. Durocher) with 2 mg of a
9:1 mixture of pOG44 Flp-Recombinase Expression Vector (Thermo Fisher) and the respective expression plasmid. The transfected
cells were then cultured in DMEM supplemented with 10%FBS, 100 U/mL penicillin, 100 mg/mL streptomycin, 10 mg/mL hygromycin
B and 5 mg/mL blasticidin in an atmosphere containing 6% CO2 at 37
C for 2 weeks to select for positive transformants. After the
selection phase the cell lines were grown in DMEM supplemented with 10% FBS, 100 U/mL penicillin, 100 mg/mL streptomycin,
5 mg/mL hygromycin B and 5 mg/mL blasticidin in an atmosphere containing 6%CO2 at 37
C. Expression of the respective constructs
was induced by adding doxycycline to the growth media at a final concentration of 1 mg/mL for 12 hr (DNA fibers) or 24 hr (immuno-
fluorescence and PLA).
RPE H2AX S139A and matching WT RPE
CRISPR/Cas9 generated H2AX S139A and the WT RPE cell line from which they originate (both kindly provided by S. Jackson) were
cultured in DMEM supplemented with 10% FBS, 100 U/mL penicillin, and 100 mg/mL streptomycin in an atmosphere containing
6% CO2 at 37
C.
U2OS ZRANB3 KO
Human osteosarcoma U2OS ZRANB3 KO cells (kindly provided by D. Cortez) were cultured in DMEM supplemented with 10% FBS,




U2OS cells were grown on sterile 12-mm diameter glass coverslip, incubated for 30 min with 10uM EdU, washed with 1X PBS and
preextracted for 10 min with CSK-buffer (10 mM PIPES, 50 mM NaCl, 300 mM Sucrose, 3 mMMgCl2, 1 mM EGTA, and 0.5% Triton
X-100) on ice, fixed in 4% buffered paraformaldehyde, washed three timea with 1X PBS, permeabilized for 10 min at room temper-
ature in 0.3% Triton X-100 (Sigma-Aldrich) in PBS and washed twice in PBS. EdU detection was performed with a Click-iT Plus EdU
Alexa Fluor 647 Imaging Kit according to the manufacturer’s recommendations (Thermo Fisher Scientific) before incubation with pri-
mary antibodies. All primary and secondary antibodies were diluted in PBS supplemented with 3%BSA. Incubation with primary an-
tibodies was performed at room temperature for 2 hr. Coverslips were washed three times with PBS containing 0.1% Tween-20
(Sigma-Aldrich). Secondary-antibody incubations were performed at room temperature for 1 hr. After one wash with PBS containing
0.1% Tween-20 and one with PBS, coverslips were incubated for 10 min with PBS containing DAPI (0.5 mg/mL) at room temperature
to stain DNA. Following three washing steps in PBS, coverslips were briefly washed with distilled water, dried on 3 mm paper and
mounted in 5 mL Prolong Gold antifade reagent (Invitrogen).
Confocal microscopy
Imagingwas performedwith support of theCenter forMicroscopy and Image Analysis, University of Zurich. Representative IF images
were acquired on a Leica SP8 automated upright confocal laser scanning microscope using an HCX PL APO CS2 63x immersion oil
objective (NA 1.4). Z series were de-convolved using Huygens Deconvolution software and a representative single Z slice is shown.
Proximity Ligation Assay (PLA)
U2OS cells were grown on sterile 12-mm diameter glass coverslip, incubated for 30 min with 10 mM EdU, washed with cold PBS
and pre-extracted in CSK buffer (HEPES-KOH 20 mM pH 7.4, 100 mM NaCl, 3 mM MgCl2, 1 mM EGTA and 0.5% Triton X-100)
for 5 min on ice. After one wash with cold PBS, cells were fixed in 4% buffered paraformaldehyde, washed three times with PBS,
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permeabilized for 10 min at room temperature in 0.3% Triton X-100 (Sigma-Aldrich) in PBS and washed twice in PBS. EdU detection
was performed according to the manufacturer’s recommendations (Thermo Fisher Scientific) before incubation with primary anti-
bodies. Coverslips were then incubated with anti-FLAG and anti-PCNA antibody and in situ proximity ligation was performed using
a Duolink Detection Kit (Sigma-Aldrich).
Quantitative image-based microscopy (QIBC)
Automatedmultichannel wide-field microscopy for QIBCwas performed as described previously (Toledo et al., 2013) on an Olympus
ScanR Screening System equipped with wide-field optics, a 20x, 0.75-NA (UPLSAPO 20x), an inverted motorized Olympus IX83
microscope, a motorized stage, IR-laser hardware autofocus, a fast emission filter wheel with single-band emission filters, and a
12-bit digital monochrome Hamamatsu ORCA-FLASH 4.0 V2 sCMOS camera (dynamic range 4,000:1, 2,048 3 2,948 pixel of size
6.5 3 6.5 mm, 12-bit dynamics). Images were acquired in an automated fashion with the ScanR acquisition software (Olympus
2.6.1). Images containing at least 2,000 cells per condition were acquired under non-saturating conditions and identical settings
were applied to all samples within one experiment. Images were processed and analyzed with the inbuilt Olympus ScanR Image
Analysis Software Version 2.5.1, a dynamic background correction was applied, nuclei segmentation was performed using an inte-
grated intensity-based object detection module using the DAPI signal, and foci segmentation was performed using an integrated
spot-detection module. Fluorescence intensities were quantified and are depicted as arbitrary units. These values were then ex-
ported and analyzed with Spotfire data visualization software (TIBCO, version 5.0.0). Within one experiment, similar cell numbers
were compared for the different conditions. To visualize discrete data in scatterplots (e.g., foci numbers), mild jittering (random
displacement of data points along the discrete data axes) was applied to demerge overlapping data points. Representative scatter-
plots and quantifications of independent experiments, typically containing several thousand cells each, are shown. Statistical anal-
ysis was performed in GraphPad Prism7 forMacOSX using paired t test.
Transfections
For siRNA experiments, cells were transfected with the indicated siRNAs for an indicated amount of time using jetPRIME (Polyplus
transfection) according to manufacturer’s instruction.
siLuc (72 hr 40 nM; 50-CGUACGCGGAAUACUUCGAUUdTdT-30);
siRNF168 (72 hr 40 nM: 50-CGUGGAACUGUGGACGAUAAUUCAAdTdT-30);
siRAD51 (24 hr 40 nM: 50-GACUGCCAGGAUAAAGCUUdTdT-30);
siRECQ1 (72 hr 40 nM: SMART pool against human RECQ1, NM_032941, Dharmacon);
siBRCA1 (72 hr 40 nM: 50-GGAACCUGUCUCCACAAAGdTdT-30);
siSmarcal1 (48 hr 40 nM:50-AAGCAAGGCCCAUCCCAAAdTdT-30).
Flow cytometric analysis for gH2A.X/EdU/DAPI
All cell lines subjected to this analysis were labeledwith 10 mMEdU for 30min, harvested by standard trypsinization and subsequently
fixed for 10 min in 4% formaldehyde/PBS. Cells were then washed twice and blocked over night at 4C with 1% BSA/PBS, pH 7.4.
They were permeabilized the next day with 0.5% saponin/1% BSA/PBS, and stained with primary mouse anti–gH2AX antibody
(05-636; EMD Millipore) diluted at 1:1000 in 0.5% saponin/1% BSA/PBS for 2 hr. This was followed by incubation with a Goat
anti-mouse Alexa 647 antibody (A-21235, Thermo Fisher) diluted at 1:125 in 0.5% saponin/1%BSA/PBS for 30min. The incorporated
EdU was labeled according to the manufacturer’s instructions (Thermo Fisher). Total DNA was stained with 1 mg/mL DAPI dissolved
in 1% BSA/PBS, pH 7.4. Samples were measured on an Attune NxT Flow Cytometer (Thermo Fisher) and analyzed using FlowJo
software V.10.0.8 (FlowJo, LLC). Statistical analysis was carried out using GraphPad Prism 7.
Replication fork progression by DNA fiber analysis
This protocol is based on Jackson and Pombo, 1998. All cell lines subjected to this analysis were grown asynchronously and labeled
with 30 mMof the thymidine analog chlorodeoxyuridine (CldU; Sigma-Aldrich) for 30min, theywere thenwashed three timeswithwarm
PBSandsubsequently exposed to 250mMof 5-iodo-20-deoxyuridine (IdU) for 30min.All cellswerecollectedby standard trypsinization
and resuspended in cold PBS at 3.53 105 cells/mL. The labeled cellsweremixed 1:8with unlabeled cells. 2.5 mL of this cell suspension
were then mixed with 7.5 mL of lysis buffer (200 mM Tris-HCl, pH 7.5, 50 mM EDTA, and 0.5% [w/vol] SDS) on a glass slide. After an
incubation of 9 min at RT, the slides were tilted at a 45 angle to stretch the DNA fibers onto the slide. The resulting DNA spreads
were air-dried, fixed in 3:1 methanol/acetic acid, and stored at 4C overnight. The DNA fibers were denatured by incubating them in
2.5MHCl for 1 hr at RT,washedfive timeswithPBSandblockedwith 2%BSA in PBST (PBSandTween20) for 40min atRT. The newly
replicatedCldUand IdU trackswere stained for 2.5hr atRTusing twodifferent anti-BrdUantibodies recognizingCldU (Abcam,ab6326)
and IdU (BectonDickinson, 347580), respectively. After washing five timeswith PBST (PBS and Tween 20) the slideswere stainedwith
Anti-mouse Alexa 488 (Invitrogen, A-11001) and anti-rat Cy3 (ImmunoResearch, 712-166-1530) secondary antibodies for 1 hr at RT in
the dark. The slides were mounted in 30 mL Prolong Gold antifade reagent (Invitrogen). Microscopy was done using an Olympus IX81
microscope with a CCD camera (Hamamatsu). To assess fork progression IdU rack lengths of at least 120 fibers per sample were
measured using the line tool in ImageJ64 software. For sister fork symmetry analysis IdU rack lengths of at least 50 sister fork fibers
were measured using the line tool in ImageJ64 software. Statistical analysis was carried out using GraphPad Prism 7.
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Neutral comet assay
Asynchronously growing U2OS shRNF168 cells were either left uninduced or depleted of RNF168 by adding doxycycline to the
growth media at a final concentration of 1 mg/mL for 96 hr. One uninduced sample was treated with 1 mM camptothecin (CPT) for
1 hr and used as a positive control for DNA double-stranded break formation. Cells were collected by standard trypsinization and
resuspended in cold PBS at a concentration of 106 cells/mL. 20 mL of cell suspension was then mixed with 600 mL of 0.8% w/v
Low Melting Point (LMP) agarose (Lonza) in PBS, previously equilibrated to 37C. 60 mL of the cell-LMP mixture was then spread
onto a comet slide (CometAssay Kit, Trevigen). Slides were incubated at 4C for 20 min to allow solidification of the LMP. They
were subsequently put in lysis buffer (CometAssay Lysis Solution, Trevigen) pre-equilibrated to 4C and refrigerated overnight.
The following day, slides were incubated in cold electrophoresis buffer (300 mM sodium acetate, 100 mM Tris, pH 8.3) for 1 hr at
4C and then subjected to electrophoresis in a comet chamber for 30 min at 21Volt/300mA. After electrophoresis, the slides were
rinsed twice in water, fixed in 70% ethanol at 4C for 20 min and then dried at 37C. The comets were than stained using SYBR
Gold (Thermo Fisher Scientific) diluted at 1:30,000 in Tris-EDTA (10 mM Tris-HCl pH 7.5, 1 mM EDTA) for 30 min in dark. Microscopy
was performed on a Leica DM6 B upright digital research microscope equipped with a DFC360 FX Leica camera at 10x magnifica-
tion. The images were analyzed using the Open Comet plugin (http://www.cometbio.org) for Fiji. At least 105 cells were analyzed per
sample. Statistical analysis was carried out using GraphPad Prism 7.
Protein extraction and western blotting
Extracts from all cell lines were prepared in Laemmli sample buffer (4%SDS, 20%glycerol, and 120mMTris- HCl, pH 6.8). 40 mg total
protein from cell isolates were loaded onto 4%–20%Mini-PROTEAN TGX Precast Protein Gels (BIO RAD). Proteins were separated
by electrophoresis at 16 mA followed by transferring the proteins to Immobilon-P membranes (Thermo Fisher Scientific) for 1 hr at
350 mA (4C) in transfer buffer (25 mM Tris and 192 mM glycine) containing 10% methanol. Before addition of primary antibodies,
membranes were blocked for 1 hr in TBS containing 0.1% Tween 20 and 5% milk.
Production of GST-tagged RNF168 and GST pull-down
For the production recombinant GST-tagged human RNF168 (GST-RNF168) protein pGEX-6P2 RNF168 was transformed into
BL21(DE3)pLysS competent bacteria. Next morning, cells were grown in 1 L of 2x TY containing 100 mg/mL Ampicillin, 50 mg/mL
Chloramphenicol to an OD600 = 0.6. Expression of GST-tagged RNF168 was induced by the addition of 0.5 mM IPTG and cells
were grown over night at 18C in a shaker. Next day, bacteria were harvested by centrifugation and pellets were lysed in 50 mM
HEPES (pH 7.5), 200 mM NaCl, 1 mM EDTA, 0.1% IPEGAL, 5% Glycerol, 1 mM PMSF, 1x Protease inhibitor cocktail (Sigma;
P8349). Subsequently to sonication and clearing of the lysate, GST-RNF168was purified by incubating cell lysates with 500 mLGluta-
thione Sepharose (GEHealtcare; 17-0756-01) for 2 hr at 4 on a rotator. Thereafter, Glutathione Sepharosewaswashed three times in
1x PBS containing 1% Triton X-100, twice with 1x PBS containing 300 mM NaCl and before two washes with and storage in main-
taining buffer (50 mM Tris-HCl pH 7.4, 100 mM NaCl, 10% Glycerol, 1 mM EDTA, 1 mM DTT).
HeLa cells were grown to 70% confluency before cell lysis in lysis buffer containing 50mMHEPES (pH 7.5), 10%Glycerol, 150mM
NaCl, 1%Triton X-100 1mMEDTA, 1mMEGTA, 10mMNEM, 10mMSodiumPyruvate, 50mMSodium Fluoride, 1mMPMSF, 1mM
MgCl2, 100 U/mL Benzonase (Sigma, E1014), 1x Protease inhibitor cocktail (Sigma; P8340). Lysates were cleared by centrifugation.
For GST pull-down experiments 500 mg of HeLa total cell extract was incubated with either 10 mg Glutathione Sepharose bound GST
or GST-tagged RNF168. Samples were analyzed by western blotting by using mouse anti-PCNA antibody (Santa-Cruz; sc-56).
CoIP
2.5 3 106 HeLa cells were transfected with pcDNA3.1 FLAG or pcDNA3.1 FLAG expressing FLAG-tagged human RNF168 using
Lipofectamine 2000 (Thermo Fisher, 11668019) following the manufacturer’s instructions. After 24 hr, cells were washed once in
1x cold PBS and lysed in lysis buffer indicated in the section above. 500 mg of cleared cell lysate was subjected to immunoprecip-
itation using 30 mL anti-FLAG M2 Affinity Gel (Sigma; A2220) and samples were incubated for 3 hr at 4C on a rotator. After four
washing steps with lysis buffer, FLAG beads were denatured in 30 mL 1x Laemmli buffer for 5 min at 95C.
iPOND
HEKT293T cells were treated either with siLuc (samples: mock, Thy and no Click) or siRNF168 as described above. For iPOND exper-
iment, cells were labeled with 10 mM EdU (Life Technologies; A10044) for 13 (siLuc) or 18 min (siRNF168). For the pulse-chase with
Thymidine (Thy Chase), EdU-labeled cells were washed twice with 1x PBS followed by incubation in cell culture medium supple-
mented with 10 mM Thymidine (Sigma-Aldrich; T1895) for 47 min. For the sample treated with 1 mM CPT (Sigma; C9911), cells
were labeled with EdU for 7 min followed by CPT treatment for 30 min. Thereafter, cells were fixed in 1% Formaldehyde (Sigma;
F1635) for 12 min and quenched with 0.125 M Glycine (AppliChem; 131340.1211) for 5 min. After removal of supernatant, cells
were then scraped off in 1x PBS followed by permeabilization in 1x PBS containing 0.25% Triton X-100 (Sigma; T9284). For the
Click-IT, cells were washed once in 1x PBS. Cell pellets were resuspended in 1x PBS containing 10 mM Sodium ascorbate (Sigma;
A7631), 2 mM CuSO4 (Sigma; 209198) and either 1 mM Biotin azide (Warburg University) or 1 mM DMSO (Sigma; A3672) and incu-
bated at RT for 2 hr on a rotator. Subsequently, cells were washed three times in 1x PBS, lysed in 50 mM Tris-HCl (pH 8), 1%
SDS supplemented with cOmplete Protease Inhibitor (Roche) and chromatin was solubilized by sonication using a Bioruptor
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(Diagenode). Cell lysates were cleared by centrifugation for 30 min at maximum speed. Cleared lysates were diluted 1:1 in 1x PBS
and binding to streptavidin-agarose (Novagen; 69203) was performed over night at 4C. Next morning, beads were washed once in
1x PBS, once in 1MNaCl and again twice in 1x PBS before de-crosslinking two times for 15min in 2x Laemmli-Buffer. Samples were
analyzed by western blotting by using the following antibodies: mouse anti-PCNA (Santa-Cruz; sc-56), rabbit anti-H2AX (Abcam;
ab11175) and mouse gH2AX (EMD Millipore; 05-636).
Enrichment for mitochondrial DNA
Mitochondrial DNA was enriched using a mitochondrial DNA Isolation Kit (Abnova; KA0895) according to the manufacturer’s instruc-
tions. Subsequently the DNA was purified and concentrated, using Amicon size-exclusion columns (Amicon ultra 100K membrane,
Millipore) and finally resuspended in TE (Tris-EDTA) buffer.
Neutral and denaturing EM analysis of DNA RIs in human cells
The procedure was performed as recently described (Zellweger and Lopes, 2018) and in the same manner for all cellular systems
presented in this manuscript. A total of 2.5–5.03 106 asynchronously growing subconfluent cells were harvested by standard tryp-
sinization and resuspended in 10 mL cold PBS. In vivo psoralen cross- linking of the DNAwas performed by exposing twice the living
cells to 4,50,8-trimethylpsoralen at a final concentration of 10 mg/mL followed by short (3 min) irradiation pulses with UV 365-nm
monochromatic light (UV Stratalinker 1800; Agilent Technologies). The cells were then washed repeatedly with cold PBS and lysed
using a cell lysis buffer (1.28 M sucrose, 40 mM Tris-Cl, pH 7.5, 20 mMMgCl2, and 4% Triton X-100). The thus obtained nuclei were
then digested using a digestion buffer (800 mM guanidine-HCl, 30 mM Tris-HCl, pH 8.0, 30 mM EDTA, pH 8.0, 5% Tween 20, and
0.5%Triton X-100) supplementedwith 1mg/mL proteinase K at 50C for 2 hr. A 24:1 Chloroform:Isoamyl alcohol mixture was used to
extract genomic DNA by phase separation (centrifugation at 8,000 rpm for 20 min at 4C). The DNAwas then precipitated by addition
of equal amount of isopropanol to the aqueous phase, followed by another centrifugation step (8,000 rpm for 10 min at 4C). The
resulting DNA pellet was washed once with 1 mL of 70% ethanol, air-dried at RT, and finally resuspended by incubating it overnight
in 200 mL TE (Tris-EDTA) buffer at RT. 12 mg of the extracted genomic DNAwas digested for 5 hr at 37Cwith 100U restriction enzyme
PvuII high-fidelity. QIAGEN-tip 20 Plasmid Mini Kit columns were used for RI enrichment. The surface tension of the columns was
reduced by incubation with QBT buffer (750 mM NaCl, 50 mM MOPS, pH 7.0, 15% isopropanol [v/v], 0.15% Triton X-100 [v/v]),
they were then washed three times with washing buffer 1 (1 M NaCl, 10 mM Tris-HCl, pH 8.0) and finally equilibrated using equilibra-
tion buffer (300mMNaCl, 10mMTris-HCl, pH 8.0). Next, the digested genomic DNAwas applied to the columns followed bywashing
twice with washing buffer 2 (900 mM NaCl, 10 mM Tris-HCl, pH 7.0). The DNA was then eluted with 0.6 mL elution buffer (1 M NaCl
10 mM Tris-HCl 1.8% caffeine). Subsequently the DNA was purified and concentrated, using Amicon size-exclusion columns
(Amicon ultra 100K membrane, Millipore) and finally resuspended in TE (Tris-EDTA) buffer. For native DNA spreading the benzyldi-
methylalkylammonium chloride (BAC) method was used to spread the DNA on a water surface and then load it on carbon-coated
400-mesh magnetic nickel grids. For denaturing spreading the spreading mix consisted of 1.0 mL formamide, 0.2 mL glyoxal and
1 mL DNA sample (10-50 ng). This mixture was incubated for 10 min at 42C in a water bath and chilled immediately after on ice. After
this denaturation step the mixture was spread by the BAC method onto carbon-coated 400-mesh magnetic nickel grids. After the
spreading procedure, the DNA was platinum coated by platinum-carbon rotary shadowing (High Vacuum Evaporator MED 020;
Bal-Tec) to make it electron dense. The grids were scanned using a transmission electron microscope (Tecnai G2 Spirit; FEI;
LaB6 filament; high tension % 120 kV) and pictures were acquired with a side mount charge-coupled device camera (2,600 3
4,000 pixels; Orius 1000; Gatan, Inc.). The images were processed with DigitalMicrograph Version 1.83.842 (Gatan, Inc.) and
analyzed using ImageJ64. Graphs were prepared and statistics performed in GraphPad Prism 7 using paired t test where applicable.
Chromosomal breakage and abnormalities by metaphase spreading
Asynchronously and sub-confluent cells were incubated in freshmedium containing 200 ng/mL nocodazole for 16 hr. They were then
harvested by standard trypsinization and swollen with 75 mM KCl for 20 min at 37C. The swollen mitotic cells were fixed using a
fixing solution (3:1 methanol:acetic acid). The fixing step was repeated twice and the cells subsequently resuspend in 200–400 mL
of fixing solution. The cells were then dropped onto pre-hydrated glass microscopy slides and air-dried overnight. The slides
were mounted the following day using VECTASHIELD Antifade Mounting Medium with DAPI (VECTOR Laboratories). Microscopy
was performed on a Leica DM6 B upright digital research microscope equipped with a DFC360 FX Leica camera. Images were
analyzed using ImageJ64 and visible chromatid breaks/gaps were counted. Statistical analysis was performed in GraphPad Prism7
for MacOSX using paired t test.
Neutral-neutral 2D-gel analysis
Asynchronously growing U2OS shRNF168 cells either left untreated or depleted of RNF168 by adding doxycycline to the growth
media (1 mg/mL final concentration, 96 hr) were transfected with an SV40 based plasmid containing 90 TTC repeats using jetPRIME
(Polyplus transfection). The cells were harvested 48 hr after transfection and plasmid DNA was extracted using a modified QIAprep
Spin Miniprep protocol. The cells were first resuspended in buffer P1 (QIAprep Spin Miniprep kit), lysed with 0.66% SDS and finally
incubated with 0.5 mg/mL proteinase K for 1.5 hr at 37C. The DNA was denatured by 25 mM NaOH for 1 min followed by
neutralization with buffer P3 (QIAprep Spin Miniprep kit), and spun for 15 min in a benchtop centrifuge at 18,200 rpm. The resulting
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supernatant was processed on miniprep columns (QIAprep Spin Miniprep kit) according to manufacturer’s instructions. The thus ex-
tracted plasmid intermediates were digested by EcoRI- DpnI-XmnI followed by EtOHprecipitation and resuspension in TE buffer. The
intermediates were then loaded onto 2D gels. The first dimensionwas run on a 0.4%agarose gel (50V, 14.5 hr) and the second dimen-
sion was run on a 1% agarose gel with EtBr (140V, 9 hr). All gels were blotted onto Bio-Rad Zeta-probe membranes and probed with
radioactively labeled SV40 DNA.
Drugs and reagents
Camptothecin was made fresh for every experiment by dissolving in dimethyl sulfoxide (DMSO) to yield a 20 mM stock (7 mg/mL).
Olaparib (AZD2281, Ku-0059436; S1060, Selleckchem) was prepared in DMSO to yield a concentration of 20 mM, aliquoted, and
stored at 20C. Mirin (M9948, Sigma-Aldrich) was dissolved in DMSO to produce a 50 mM stock, aliquoted and stored at
80C. The ATM inhibitor KU-55933 (Sigma-Aldrich) was dissolved in DMSO to yield a stock concentration of 10 mM, aliquoted
and stored at 20C.
Antibodies
The following primary antibodies were used for western blotting: GAPDH (MAB374, Millipore, kindly provided by A. Sartori), B tubulin
(sc-9104; Santa Cruz Biotechnology), CHK1 pS345 rabbit (2348; Cell Signaling Technology), CHK1 mouse (sc-8408; Santa Cruz
Biotechnology), KAP1 pS824 rabbit (A300-767A; Bethyl Laboratories), KAP1 rabbit (A300-274A; Bethyl Laboratories), phospho-
RPA32 (S4/S8) rabbit (A300-245A; Bethyl Laboratories), RPA32 rabbit (A300-244A; Bethyl Laboratories), RAD51 (H-92) rabbit (sc-
8349; Santa Cruz Biotechnology), 53BP1 rabbit (ab36823 Abcam) RNF168 rabbit (generated by R. Freire), RNF8 rabbit (generated
by R. Freire). RECQ1 rabbit (ABC1428, Sigma-Aldrich, kindly provided by A. Vindigni). Secondary antibodies used for western blot-
ting were anti-rabbit and anti-mouse ECL (GE Healthcare) The following primary antibodies were used for IF and PLA: FLAG rabbit
(F7425, Sigma-Aldrich), FLAG mouse (M2 clone, F1804, Sigma-Aldrich), PCNA mouse (P10, sc-56, Santa Cruz Biotechnology),
H2AK15Uub mouse (generated and kindly provided by the lab of Z. Zhang Mayo Clinic College of Medicine, Rochester, Minnesota,
USA) and gH2AX rabbit (9718, Cell Signaling). Antibodies recognizing human RNF8 and RNF168 were raised in rabbits. To obtain the
purified immunogens, the cDNA corresponding to full-length human RNF8 and to the C-terminal part of human RNF168 (amino acids
300-571) were cloned into pET28a (Novagen) vector for expression in Escherichia coli. Subsequently, the recombinant immunogens
were purified using Ni-NTA (QIAGEN) following the manufacturer’s instructions and then used to immunize rabbits. After eight immu-
nizations, serum was obtained and used for western blots.
DATA AND SOFTWARE AVAILABILITY
Raw imaging data have been deposited to Mendeley Data at https://doi.org/10.17632/hkjz8w9c6p.1.
QUANTIFICATION AND STATISTICAL ANALYSIS
For DNA fiber experiments at least 120 IdU tracts were scored per sample for fork progression analysis and at least 50 sister forks for
sister fork symmetry analysis. Every experiment was repeated at least twice. The results were analyzed using GraphPad Prism7 for-
MacOSX, using Mann-Whitney test. Whiskers: 10th-90th percentile (****p < 0.0001; ***p < 0.001; ns, non-significant). Flow cytometry
data were analyzed using FlowJo software V.10.0.8 (FlowJo, LLC). The intensity values of 500 EdU positive cells per sample were
extracted from the raw data and subjected to statistical analysis using GraphPad Prism 7 (****p value < 0.0001; whiskers: 10th–
90th percentile) For the neutral comet assay, at least 105 cells were analyzed per sample for Olive- and Tail-moment using the
Open Comet plugin (http://www.cometbio.org/) for Fiji. The experiment was repeated 3 times with comparable results. The results
were analyzed using GraphPad Prism7 forMacOSX, using Mann-Whitney test. Displayed as scatterplots with mean and SD
(****p < 0.0001; ns, non-significant). For quantitative image-based microscopy images were processed and analyzed with the inbuilt
Olympus ScanR Image Analysis Software Version 2.5.1. Fluorescence intensities were quantified and depicted as arbitrary units.
These values were then exported and analyze with Spotfire data visualization software (TIBCO, version 5.0.0). Within one experiment,
similar cell numbers were compared for all different conditions. To visualize discrete data in scatterplots (e.g., foci numbers), mild
jittering (random displacement of data points along the discrete data axes) was applied to demerge overlapping data points. Repre-
sentative scatterplots and quantifications of independent experiments, typically containing several thousand cells each, are shown.
Every neutral electron microscopy experiment was repeated twice the number of molecules per sample is indicated in the respective
figures and the accompanying EM table. The data were depicted as bar plots with GraphPad Prism7 for MacOSX. For denaturing EM
analysis, the bubble size from 20 reversed forks was measured using ImageJ64 resulting in a total of 123 bubbles for the regressed
arm, 372 for the parental strand and 600 for the two daughter strands. Frequency distributions for all strand types were computed
using GraphPad Prism7 for MacOSX and plotted as histograms with a bin width of 30 nucleotides.
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